GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (CHIX:CNWKd) » Definitions » EBITDA Margin %

Codon AG (CHIX:CNWKD) EBITDA Margin % : -183.36% (As of Jun. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Codon AG EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Codon AG's EBITDA for the six months ended in Jun. 2022 was €-5.97 Mil. Codon AG's Revenue for the six months ended in Jun. 2022 was €3.26 Mil. Therefore, Codon AG's EBITDA margin for the quarter that ended in Jun. 2022 was -183.36%.


Codon AG EBITDA Margin % Historical Data

The historical data trend for Codon AG's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codon AG EBITDA Margin % Chart

Codon AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -95.62 -26.35 -113.56 -159.96 -71.71

Codon AG Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -190.07 -135.41 -164.51 -26.30 -183.36

Competitive Comparison of Codon AG's EBITDA Margin %

For the Biotechnology subindustry, Codon AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Codon AG's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Codon AG's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Codon AG's EBITDA Margin % falls into.



Codon AG EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Codon AG's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-7.03/9.803
=-71.71 %

Codon AG's EBITDA Margin % for the quarter that ended in Jun. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2022 )/Revenue (Q: Jun. 2022 )
=-5.974/3.258
=-183.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Codon AG  (CHIX:CNWKd) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Codon AG EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Codon AG's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Codon AG (CHIX:CNWKD) Business Description

Traded in Other Exchanges
N/A
Address
Warthestrasse 21, Teltow, DEU, 14513
Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.

Codon AG (CHIX:CNWKD) Headlines

No Headlines